Optimizing Value-Based Drug Pricing in Japan wi...

By João L. Carapinha

April 24, 2025

The article reviews MARIE, a qualitative multiple-criteria value-based drug pricing (VBP) framework designed for the Japanese drug pricing system to address price adjustments for drugs with updated clinical status. By applying MARIE to 32 drugs, a...
Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...
NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and ...
Cost-Effective HIV PrEP: CAB-LA Transforms Prevention
Global Health Limitations: A Critical Assessment of Structural Constraints an...
Enhancing UK Clinical Trials Inclusivity: Opportunities and Innovations in Me...
Cost-Effective Interventions for HIV, Malaria, Syphilis, and TB in 128 Countries
Advancing Early Childhood Health: PureHealth’s Partnership with Abu Dha...
Balancing Pandemic Preparedness Priorities and Military Spending
Reassuring the Private Sector on National Health Insurance South Africa: A Pa...
Exploring the MASLD CKD Socioeconomic Link
Toripalimab Evidence Journey in Cancer Care